BIOFLOW-china Post-marketing Study (BIOTRONIK)
Stopped According to the renewal registration certificate requirements issued by the NMPA, this product does not need to collect post-market safety data.
Conditions
- In-Stent Stenosis (Restenosis) of Coronary Artery Stent
- Native Coronary Artery Stenosis
Interventions
- DEVICE: BIOTRONIK Orsiro Sirolimus-Eluting Coronary Stent System
Sponsor
Biotronik (Beijing) Medical Device Ltd.
Collaborators